Related Experiment Video
Updated: Jun 21, 2026

07:42
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
cAMP signaling in Mycobacterium tuberculosis.
Nisheeth Agarwal1, William R Bishai
1Departtment of Medicine, Johns Hopkins School of Medicine, CRB2, Rm 1.08, 1550 Orleans Street, Baltimore, Maryland 21231-1044, USA.
Indian Journal of Experimental Biology
|July 29, 2009
Summary
Cyclic adenosine monophosphate (cAMP) is a key signaling molecule. Mycobacterium tuberculosis utilizes complex cAMP signaling, with seventeen adenylate cyclase homologues, impacting its biology.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Cyclic adenosine monophosphate (cAMP) functions as a crucial second messenger in diverse organisms.
- Bacterial pathogens can disrupt host cAMP signaling through toxin activity.
- Mycobacterium tuberculosis possesses an unusually large number of adenylate cyclase homologues.
Purpose of the Study:
- To provide an overview of cAMP's role as a second messenger.
- To discuss bacterial strategies for subverting host cAMP signaling.
- To review current knowledge on cAMP signaling in Mycobacterium tuberculosis.
Main Methods:
- Literature review of cAMP signaling.
- Analysis of bacterial toxin mechanisms.
- Examination of Mycobacterium tuberculosis adenylate cyclase homologues.
Main Results:
- cAMP is a vital second messenger across prokaryotes and eukaryotes.
- Pathogenic bacteria employ toxins to manipulate host cAMP pathways.
- Mycobacterium tuberculosis exhibits a complex cAMP signaling system with 17 adenylate cyclase genes.
Conclusions:
- cAMP signaling is fundamental in microbial and host cell biology.
- Understanding bacterial manipulation of cAMP is key to pathogenesis.
- The extensive adenylate cyclase repertoire in M. tuberculosis highlights the significance of cAMP in its biology.
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

